Michael Gray

Michael Paul Gray currently works at The American Institute of Certified Public Accountants, as Member and Upstream Bio, Inc., as Chief Financial & Operating Officer from 2024.
Mr. Gray also formerly worked at X4 Pharmaceuticals, Inc., as President, Chief Executive Officer & CFO from 2018 to 2019, Arsanis, Inc., as President, CEO, Chief Financial Officer & Director from 2018 to 2022, Therapeutics Acquisition Corp., as Independent Director from 2020 to 2021, Curis, Inc., as Secretary, Chief Financial & Business Officer from 2014 to 2016, Tetraphase Pharmaceuticals, Inc., as Chief Financial Officer & Senior Vice President, Reprogenesis, Inc., as Controller from 1998 to 2000, Enliven Therapeutics, Inc., as Chief Financial & Operating Officer from 2019 to 2023, Carmot Therapeutics, Inc., as Chief Operating & Financial Officer from 2023 to 2024, and Imara, Inc., as Chief Financial & Operating Officer from 2019 to 2023.
Mr. Gray received his undergraduate degree from Bryant University and Masters Business Admin degree from F.W.
Olin Graduate School of Business.